Fluorescent humanized anti-CEA antibody specifically labels metastatic pancreatic cancer in a patient-derived orthotopic xenograft (PDOX) mouse model.

Saved in:
Bibliographic Details
Title: Fluorescent humanized anti-CEA antibody specifically labels metastatic pancreatic cancer in a patient-derived orthotopic xenograft (PDOX) mouse model.
Authors: Lwin TM; Department of Surgery, University of California San Diego, San Diego, CA, USA., Miyake K; Department of Surgery, University of California San Diego, San Diego, CA, USA.; AntiCancer, Inc., San Diego, CA, USA.; Department of Gastroenterological Surgery, Yokohama City University, Graduate School of Medicine, Yokohama, Japan., Murakami T; Department of Surgery, University of California San Diego, San Diego, CA, USA.; AntiCancer, Inc., San Diego, CA, USA.; Department of Gastroenterological Surgery, Yokohama City University, Graduate School of Medicine, Yokohama, Japan., DeLong JC; Department of Surgery, University of California San Diego, San Diego, CA, USA., Amirfakhri S; VA San Diego Healthcare System, San Diego, CA, USA., Filemoni F; VA San Diego Healthcare System, San Diego, CA, USA., Yoon SN; Department of Surgery, University of California San Diego, San Diego, CA, USA.; AntiCancer, Inc., San Diego, CA, USA., Yazaki PJ; Department of Molecular Imaging and Therapy, City of Hope, Duarte, CA, USA., Shivley JE; Department of Molecular Imaging and Therapy, City of Hope, Duarte, CA, USA., Datnow B; Department of Pathology, University of California San Diego, San Diego, CA, USA., Clary BM; Department of Surgery, University of California San Diego, San Diego, CA, USA., Hoffman RM; Department of Surgery, University of California San Diego, San Diego, CA, USA.; AntiCancer, Inc., San Diego, CA, USA.; VA San Diego Healthcare System, San Diego, CA, USA., Bouvet M; Department of Surgery, University of California San Diego, San Diego, CA, USA.; VA San Diego Healthcare System, San Diego, CA, USA.
Source: Oncotarget [Oncotarget] 2018 Dec 18; Vol. 9 (99), pp. 37333-37342. Date of Electronic Publication: 2018 Dec 18 (Print Publication: 2018).
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1949-2553
DOI:10.18632/oncotarget.26484